These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4067005)

  • 1. Lorazepam use and catatonic syndrome.
    Peterson GN
    J Clin Psychopharmacol; 1985 Dec; 5(6):359-60. PubMed ID: 4067005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of catatonia with lorazepam].
    González-Seijo JC; Ramos Vicente YM; Lastra Martínez I; Carbonell Masía C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1993; 21(3):90-4. PubMed ID: 8101421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECT for lorazepam-refractory catatonia.
    Yeung PP; Milstein RM; Daniels DC; Bowers MB
    Convuls Ther; 1996 Mar; 12(1):31-5. PubMed ID: 8777651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia.
    Petrides G; Divadeenam KM; Bush G; Francis A
    Biol Psychiatry; 1997 Sep; 42(5):375-81. PubMed ID: 9276078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers.
    Gaind GS; Rosebush PI; Mazurek MF
    J Clin Psychiatry; 1994 Jan; 55(1):20-3. PubMed ID: 8294387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response rate of lorazepam in catatonia: a developing country's perspective.
    Tibrewal P; Narayanaswamy J; Zutshi A; Srinivasaraju R; Math SB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1520-2. PubMed ID: 20804808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia: Treatment Characteristics and Outcomes in 60 Patients.
    Unal A; Altindag A; Demir B; Aksoy I
    J ECT; 2017 Dec; 33(4):290-293. PubMed ID: 28640169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy and malignant catatonia.
    Espínola-Nadurille M; Ramírez-Bermúdez J; Fricchione GL
    Gen Hosp Psychiatry; 2007; 29(1):69-71. PubMed ID: 17189750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy.
    Bush G; Fink M; Petrides G; Dowling F; Francis A
    Acta Psychiatr Scand; 1996 Feb; 93(2):137-43. PubMed ID: 8686484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lorazepam treatment of psychogenic catatonia: an update.
    Salam SA; Kilzieh N
    J Clin Psychiatry; 1988 Dec; 49 Suppl():16-21. PubMed ID: 3058684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive therapy for malignant catatonia in adolescence.
    Dhossche DM; Shettar SM; Kumar T; Burt L
    South Med J; 2009 Nov; 102(11):1170-2. PubMed ID: 19864990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-refractory catatonia, ECT, and parenteral lorazepam.
    Koek RJ; Mervis JR
    Am J Psychiatry; 1999 Jan; 156(1):160-1; author reply 161. PubMed ID: 9892323
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment-refractory catatonia, ECT, and parenteral lorazepam.
    Armstrong SC
    Am J Psychiatry; 1999 Jan; 156(1):160; author reply 161. PubMed ID: 9892322
    [No Abstract]   [Full Text] [Related]  

  • 14. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam.
    Rosebush PI; Hildebrand AM; Furlong BG; Mazurek MF
    J Clin Psychiatry; 1990 Sep; 51(9):357-62. PubMed ID: 2211547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous lorazepam in neuroleptic-induced catatonia.
    Fricchione GL; Cassem NH; Hooberman D; Hobson D
    J Clin Psychopharmacol; 1983 Dec; 3(6):338-42. PubMed ID: 6139391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepines in the treatment of catatonic syndrome.
    Ungvari GS; Leung CM; Wong MK; Lau J
    Acta Psychiatr Scand; 1994 Apr; 89(4):285-8. PubMed ID: 8023696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte abnormality in catatonia: revisiting the immune theory of catatonia.
    Rao NP; Mutalik NR; Kasal V; Venkatasubramanian G; Behere RV; Varambally S; Gangadhar BN
    J ECT; 2011 Sep; 27(3):e53-4. PubMed ID: 21865953
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical predictors of response to treatment in catatonia.
    Narayanaswamy JC; Tibrewal P; Zutshi A; Srinivasaraju R; Math SB
    Gen Hosp Psychiatry; 2012; 34(3):312-6. PubMed ID: 22387048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
    Hatta K; Miyakawa K; Ota T; Usui C; Nakamura H; Arai H
    J ECT; 2007 Dec; 23(4):233-5. PubMed ID: 18090694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent catatonia for 1.5 years finally resolved with electroconvulsive therapy.
    Bülbül F; Ünal A; Çöpoğlu ÜS; Alpak G; Savaş HA
    J ECT; 2013 Mar; 29(1):e1. PubMed ID: 23422525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.